Cargando…
One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics
Tuberculosis (TB) remains a global health problem despite almost universal efforts to provide patients with highly effective chemotherapy, in part, because many infected individuals are not diagnosed and treated, others do not complete treatment, and a small proportion harbor Mycobacterium tuberculo...
Autores principales: | Yang, Hee-Jeong, Wang, Decheng, Wen, Xin, Weiner, Danielle M., Via, Laura E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008060/ https://www.ncbi.nlm.nih.gov/pubmed/33796474 http://dx.doi.org/10.3389/fcimb.2021.613149 |
Ejemplares similares
-
Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease
por: Osorio-Méndez, Juan Felipe, et al.
Publicado: (2019) -
Impact of Genetic Diversity and Genome Plasticity of Leishmania spp. in Treatment and the Search for Novel Chemotherapeutic Targets
por: Santi, Ana Maria Murta, et al.
Publicado: (2022) -
Tripterygium glycosides sensitizes cisplatin chemotherapeutic potency by modulating gut microbiota in epithelial ovarian cancer
por: Zhan, Xinlu, et al.
Publicado: (2023) -
E3 Ligase FBXW7 Facilitates Mycobacterium Immune Evasion by Modulating TNF-α Expression
por: Song, Jingrui, et al.
Publicado: (2022) -
Ex vivo and in vivo evidence that cigarette smoke-exposed T regulatory cells impair host immunity against Mycobacterium tuberculosis
por: Bai, Xiyuan, et al.
Publicado: (2023)